A potent and selective pan-ALK inhibitor IC50=0.6 nM. Cells with ALK mutation L1196Q and the double mutation I1171S + G1269 remain sensitive to brigatinib. Clinically useful in non-small cell lung cancer
Know who made it. See the evidence. Buy through one marketplace.
A potent and selective pan-ALK inhibitor IC50=0.6 nM. Cells with ALK mutation L1196Q and the double mutation I1171S + G1269 remain sensitive to brigatinib. Clinically useful in non-small cell lung cancer
This product is manufactured by TriBio Science and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
